Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongxinluo for High Platelet Reactivity in ACS
NCT01721590Phase 4Completed
- Start
- Nov 2012
- Primary completion
- May 2013
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongxinluo in acute coronary syndrome (ACS) (2 arms). Primary endpoint: Platelet Reaction Unit at 30 days. Started Nov 2012; status: completed.
02
Drugs
Tongxinluo
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01721590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01721590.